Replies to post #596998 on NorthWest Biotherapeutics Inc (NWBO)

[dennisdave]

There were no issues with CRL when they produced DCVAXL for the trial. Also if CRL is such a risk then why would LP state at the last ASM she plans to contract them for the US?

Besides Advent and CRL are BOTH third-party CDMOs to NWBO.
Building a CDMO is much more riskier then working together with CRL to get MIA

[Bright Boy]

Brilliant comment AND if you can't produce/manufacture what you're selling and need a major to do it for you, YOU ARE SCREWED!!!

Lessons I learned the hard way!!!

Cheers,

BB